mayne and sirtex? Read todays Mayne news from CEO. He is firmly committed to his oncology franchise and will be acquiring growing oncology franchises and companies.Previously I said the most likely acquirers of Sirtex would be Pfizer,Aventis, Bristol Myers, Genentech, Cephalon, or Mayne. After carefully reading todays Mayne news I would believe that Mayne is now the most likely suitor. It would have to beat by alot the previous 2003 Cephalon bid of $4.85, as now Sirtex is highly profitable and growing over 100%+.Read the Mayne news carefully. My opinion after being in the industry along time. Do your own work.
along for the ride?, page-16
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.15M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 17.0¢ | $9.433K | 55.49K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 6879273 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 235544 | 5 |
View Market Depth
| Last trade - 10.41am 06/08/2024 (20 minute delay) ? |
| SRX (ASX) Chart |